Meeker David P — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Meeker David P has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Profile

David P. Meeker is identified in SEC filings as the President and Chief Executive Officer of Rhythm Pharmaceuticals, Inc., as of February 13, 2026. The provided SEC context confirms that he holds the top executive role at Rhythm Pharmaceuticals. No additional biographical details (such as education or prior positions) are included in the given context.

Board memberships

• Rhythm Pharmaceuticals, Inc.

Awards & honors

• Serves as President and CEO of Rhythm Pharmaceuticals, Inc. (as of 2026-02-13)

Recent Transactions

Companies — Last 90 Days

• Kardigan, Inc. (KARD) — 1 filings, last 2026-06-22
• Trevi Therapeutics, Inc. (TRVI) — 1 filings, last 2026-06-04

Frequently Asked Questions

Who is Meeker David P?

David P. Meeker is identified in SEC filings as the President and Chief Executive Officer of Rhythm Pharmaceuticals, Inc., as of February 13, 2026. The provided SEC context confirms that he holds the top executive role at Rhythm Pharmaceuticals. No additional biographical details (such as education or prior positions) are included in the given context.…

How many SEC Form 4 filings has Meeker David P submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Where can I see all of Meeker David P's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week